2020 American Transplant Congress
The Incidence, Clinical Characteristics and Prophylactic Strategy of Invasive Fungal Infections in Lung Transplantation
*Purpose: Invasive Fungal infections in lung transplant recipients(LTR) were common and harmful, remaining a major cause of morbidity and mortality after lung transplantation. The incidence,…2020 American Transplant Congress
Pentamidine Prophylaxis in Transplant Recipients
Department of Pharmacy, Henry Ford Hospital, Detroit, MI
*Purpose: Trimethoprim-sulfamethoxazole (TMP-SMX) is preferred therapy for pneumocystis pneumonia (PJP) prophylaxis in solid organ transplant (SOT) recipients, however, use can be limited by allergy and…2020 American Transplant Congress
A Comparative Analysis of Mucormycosis in Solid Organ Transplant Recipients and Other Immunosuppressed Hosts Including Patients with Uncontrolled Diabetes
*Purpose: Mucormycosis is a rare disease that is associated with a high morbidity and mortality. It usually affects those with uncontrolled diabetes mellitus (DM) and…2020 American Transplant Congress
Epidemiology Cytomegalovirus Infection/Disease in Kidney Transplant Recipients: A Systematic Review of Observational Studies
1Merck & Co., Inc., Kenilworth, NJ, 2Evidera, Inc., Waltham, MA, 3Tufts Medical Center, Boston, MA
*Purpose: Efficacy of several CMV anti-viral strategies has been shown in controlled trials for CMV infection/disease in kidney transplant recipients (KTRs). However, a comprehensive analysis…2020 American Transplant Congress
Rates of Urinary Tract Infections in Kidney Transplant Patients Using Trimethoprim/Sulfamethoxazole versus Alternative Agents for Pneumocystis Jiroveci Prophylaxis
Hennepin Healthcare, Minneapolis, MN
*Purpose: Trimethoprim/sulfamethoxazole (TMP/SMX) is used in kidney transplant patients for prophylaxis against Pneumocystis jiroveci pneumonia (PJP) and has demonstrated a decrease in the incidence of…2020 American Transplant Congress
Incidence of Cytomegalovirus and Role of Reduced Dose Valganciclovir in Kidney Transplant Recipients
*Purpose: Valganciclovir (VGC) is the optimal agent for preventing cytomegalovirus (CMV) but its use is limited by cost and leukopenia. Reduced dose VGC (rVGC) has…2020 American Transplant Congress
Management of Adenovirus Enteritis after Intestinal Transplantation
*Purpose: Solid organ transplant recipients are at risk for infection, in part due to immunosuppression. Adenovirus enteritis (AE) is one possible clinical presentation of infection…2020 American Transplant Congress
Efficacy of Single-Strength Trimethoprim-Sulfamethoxazole Thrice Weekly for Pneumocysitis Jirovecii Pneumonia Prophylaxis Post Liver Transplantation
Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA
*Purpose: Current guidelines recommend Pneumocystis jirovecii pneumonia (PJP) prophylaxis for at least 6-12 months after liver transplant (LTx) with preferably Trimethoprim-sulfamethoxazole (TMP-SMX) at a daily…2020 American Transplant Congress
A Population-Based Analysis of Hepatocellular Carcinoma in Children: Identifying Optimal Surgical Treatment
*Purpose: Hepatocellular carcinoma (HCC) constitutes 0.5% of childhood malignancies and exhibits poor prognosis. Complete tumor extirpation either by partial liver resection (LR) or liver transplantation…2020 American Transplant Congress
Infectious Complications in Elderly Kidney Transplant Recipients Undergoing Desensitization
Cedars Sinai Medical Center, West Hollywood, CA
*Purpose: Data is limited on the impact of desensitization on infectious complications in elderly kidney transplant (KT) recipients. We examined infectious complications in elderly KT…
- « Previous Page
- 1
- …
- 426
- 427
- 428
- 429
- 430
- …
- 1683
- Next Page »